Form 4 · Filed Jun 17, 2026, 11:45 PM UTC
ELVN/Enliven Therapeutics, Inc.
ORBIMED ADVISORS LLC — 10pct_owner
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | S | sell | 9,086 | $45 | $409,052 | 245,728 |
| Jun 15, 2026 | S | sell | 272,322 | $45 | $12,259,936 | 7,388,902 |
Source: SEC EDGAR raw filing ↗ · Accession 0000947871-26-000637